Become A Wiser, More Profitable Investor

If you don't make over $60 your first month, get your money back

Become a more profitable investor with our transparent AI stock forecasts.
Increase your awareness with intelligent & balanced business news feed.
Stay on top with forecast models models trained, tested, and updated every day.

The news feed designed to reduce addiction and increase your understanding.

Become a more profitable investor.

Adaptive, cutting edge stock/cryptocurrency forecasts

Models are trained and tested 24/7.
Our models give transparent metrics of performance/confidence so you can make smarter decisions.
Read intelligent business articles and stay up to date with intellectually & politically diverse news. Cut out the noise.
Forecasts powered by: sentiment analysis, fundamental analysis, financials, web traffic data, economic data, analyst opinions, hedge fund trading analysis, competitor analysis, search data, corporate insider activity, online ad spend, and more.
Premium members can access custom forecast alerts, see longer forecasts, and access trade suggestions.

Contact Helium Trades

* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.

United States Tech Markets Politics Business Science Memes

respiratory syncytial virus rsv

Sort By:

✅ Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia

science

CONCLUSIONS: With vaccine uptake similar to that achieved for other maternal vaccines in Australia, a year-round RSV maternal vaccination program is predicted to approximately halve the number of RSV hospitalisations in infants younger than 6 months. There was a small herd effect predicted in the base case but potential for larger benefits if vaccine coverage or the duration of protection exceeds base case assumptions.

NCBI Oct 18, 2024

Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia

Article Bias: The article presents a scientifically-grounded analysis of the potential impacts of a maternal RSV vaccination program in Australia, emphasizing empirical data and modeling to support conclusions, thus exhibiting minimal bias.

NCBI Bias

Social Shares: 0

🔵 Liberal <—> Conservative 🔴:

🗽 Libertarian <—> Authoritarian 🚔:

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📉 Bearish <—> Bullish 📈:

📝 Prescriptive:

🕊️ Dovish <—> Hawkish 🦁:

😨 Fearful:

📞 Begging the Question:

🗣️ Gossip:

💭 Opinion:

🗳 Political:

Oversimplification:

🏛️ Appeal to Authority:

🍼 Immature:

🔄 Circular Reasoning:

👀 Covering Responses:

😢 Victimization:

😤 Overconfident:

🗑️ Spam:

✊ Ideological:

🏴 Anti-establishment <—> Pro-establishment 📺:

🙁 Negative <—> Positive 🙂:

📏📏 Double Standard:

❌ Uncredible <—> Credible ✅:

🧠 Rational <—> Irrational 🤪:

🤑 Advertising:

🔬 Scientific <—> Superstitious 🔮:

🤖 Written by AI:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: Neutral in health research, data-driven responses.

Article Text:
Please login or sign up to view

respiratory syncytial virus rsv

✅ Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia

Market Forecasts

Trading Strategies

Balanced News

About

Contact Helium Trades